COMMENTARY Rachel S. Rubin, MD DISCLOSURES | July 23, 2024 This transcript has been edited for clarity. Rachel S. Rubin, MD: Hi. I’m Dr Rachel Rubin, urologist and sexual medicine specialist in the Washington, DC, area. Welcome back to another episode of Sex Matters. I have an interesting topic for you — kind of shocking,...
Tag: <span>Editorial</span>
Post
Mounjaro Beats Ozempic, So Why Isn’t It More Popular?
COMMENTARY F. Perry Wilson, MSCE, MD DISCLOSURES | July 08, 2024 This transcript has been edited for clarity. Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I’m Dr F. Perry Wilson of the Yale School of Medicine. It’s July, which means our hospital is filled with new interns, residents,...
Post
Is It Time to Rethink the Glucose Management Indicator?
Perspective > Medscape Diabetes & Endocrinology Elizabeth Selvin, PhD, MPH DISCLOSURES March 20, 2024 Continuous glucose monitoring (CGM) has revolutionized diabetes care, especially for patients with type 1 diabetes. CGM is also increasingly being used for patients with type 2 diabetes as well as managing diabetes during pregnancy. As the adoption of this technology grows,...
Post
Cholesterol Denialism is Pseudoscience
theheart.org on MedscapeCOMMENTARY Christopher Labos, MD CM, MSc, FRCPCDISCLOSURES | May 02, 2024 How did cholesterol denialism become a pseudoscience? It happened so slowly that many of us didn’t notice. But somewhere along the way, cholesterol deniers stopped questioning the scientific evidence and started denying it. Christopher Labos, MD CM, MSc If you weren’t paying...
Post
Could bird flu in cows lead to a human outbreak? Slow response worries scientists
By Smriti Mallapaty A black and white cow with yellow ID tags in it’s ears grazes in a field at a dairy farm in California. Dairy cows in nine US states have tested positive for the H5N1 influenza virus, but tests have found no infectious virus in pasteurized milk.Credit: Justin Sullivan/Getty Researchers worry that insufficient...
Post
First-Line Therapy in T2D: Has Metformin Been ‘Dethroned’?
Joshua J. Neumiller, PharmD, CDCES; Radica Z. Alicic, MD, MSc DISCLOSURES August 15, 2023Initially approved by the US Food and Drug Administration (FDA) in 1994, metformin has been the preferred first-line glucose-lowering agent for patients with type 2 diabetes (T2D) owing to its effectiveness, low hypoglycemia risk, weight neutrality, long clinical track record of safety,...
Post
Smartphones for Kids With Type 1 Diabetes: Cause for Concern?
Jessica Sparks Lilley, MD My young patient with type 1 diabetes (T1D) had her cell phone out to provide a share code for her Dexcom clarity app as she was checking into her visit. As my nurse was recording the code, the patient asked him, “Hey, can you add me on Snapchat?” Her father scrolled...
Post
The Shrinking Number of Primary Care Physicians Is Reaching a Tipping Point
By Elisabeth Rosenthal I’ve been receiving an escalating stream of panicked emails from people telling me their longtime physician was retiring, was no longer taking their insurance, or had gone concierge and would no longer see them unless they ponied up a hefty annual fee. They have said they couldn’t find another primary care doctor...
Post
First-Line Therapy in T2D: Has Metformin Been ‘Dethroned’?
Joshua J. Neumiller, PharmD, CDCES; Radica Z. Alicic, MD, MSc Initially approved by the US Food and Drug Administration (FDA) in 1994, metformin has been the preferred first-line glucose-lowering agent for patients with type 2 diabetes (T2D) owing to its effectiveness, low hypoglycemia risk, weight neutrality, long clinical track record of safety, and affordability. However,...